Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)
Abstract Background Neurofibromatosis 1 and 2, although involving two different tumour suppressor genes (neurofibromin and merlin, respectively), are both cancer predisposition syndromes that disproportionately affect cells of neural crest origin. New therapeutic approaches for both NF1 and NF2 are...
Saved in:
Main Authors: | Yu-chi Shen (Author), Caroline Arellano-Garcia (Author), Rosa E. Menjivar (Author), Ethan M. Jewett (Author), Wolfgang Dohle (Author), Sofiia Karchugina (Author), Jonathan Chernoff (Author), Barry V. L. Potter (Author), Kate F. Barald (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Arylsulfonamido-alkyl-sulfamates act as inhibitors of bovine carbonic anhydrase II
by: Toni C. Denner, et al.
Published: (2024) -
Stereochemistry matters: Inhibition of carbonic anhydrase II by amino acid derived sulfamates depends on their absolute configuration
by: Toni C. Denner, et al.
Published: (2024) -
Optic Pathway Gliomas in Neurofibromatosis 1 (NF-1)
by: J Gordon Millichap
Published: (2007) -
Early feasibility testing of a web-based mind-body resiliency program for adults with neurofibromatosis: The NF-Web study
by: Ethan G. Lester, et al.
Published: (2022) -
Presymptomatic Diagnosis of Neurofibromatosis 2
by: J Gordon Millichap
Published: (1996)